Doenças Autoimunes


Managing an IBD Infusion Unit During the COVID-19 Pandemic: Service Modifications and the Patient Perspective

Clough JN, Hill KL, Duff A, Sharma E, Ray S, Mawdsley JE, Anderson S, Irving PM, Samaan MA.

Abstract:

Link para artigo

Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review

Coskun Benlidayi I, Kurtaran B, Tirasci E, Guzel R.

Abstract:

Link para artigo

Clinical course and outcome of COVID-19 in patients with rheumatic diseases: are all biological disease-modifying antirheumatic drugs alike? Response to: 'Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab' by Schulze-Koops et al

Monti S, Montecucco C.

Abstract:

Link para artigo

Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab

Schulze-Koops H, Krueger K, Vallbracht I, Hasseli R, Skapenko A.

Abstract:

Link para artigo

Zero COVID-19 infection in inflammatory bowel disease patients: Findings from National IBD Registries in Hong Kong and Taiwan

Mak JWY, Weng MT, Wei SC, Ng SC.

Abstract:

Link para artigo

COVID-19 and rheumatology: is shielding really necessary?

Amani L, Warraich R, Patel N, Tahir H.

Abstract:

Link para artigo

Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors

Jovani V, Calabuig I, Peral-Garrido ML, Tovar-Sugrañes E, López-González MD, Bernabeu P, Martínez A, Esteve-Vives J, León-Ramírez JM, Moreno-Perez O, Boix V, Gil J, Merino E, Vela P, Andrés M.

Abstract:

Link para artigo

Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments

Gendebien Z, von Frenckell C, Ribbens C, André B, Thys M, Gangolf M, Seidel L, Malaise MG, Malaise O.

Abstract:

Link para artigo

Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic

Santos-Moreno P, Chavez-Chavez J, Hernández-Zambrano SM, Rivera-Triana DP, Castiblanco-Montañez RA, Aza A, Buitrago-Garcia D, Villarreal L, Rojas-Villarraga A.

Abstract:

Link para artigo

Response to: 'Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors' by Jovani et al

D'Silva KM, Serling-Boyd N, Wallwork R, Hsu T, Sparks JA, Wallace ZS.

Abstract:

Link para artigo

Response to: 'Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic' by Santos-Moreno et al

Bozzalla Cassione E, Zanframundo G, Biglia A, Codullo V, Montecucco C, Cavagna L.

Abstract:

Link para artigo

Rheumatology practice amidst the COVID-19 pandemic: a pragmatic view

Rom√£o VC, Cordeiro I, Macieira C, Oliveira-Ramos F, Romeu JC, Rosa CM, Saavedra MJ, Saraiva F, Vieira-Sousa E, Fonseca JE.

Abstract:

Link para artigo

Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2-exploring RAS inhibitors-authors' reply

Taxonera C, Sagastagoitia I, Alba C, Mañas N, Olivares D, Rey E.

Abstract:

Link para artigo

Stopping Clinical Trials in Inflammatory Bowel Disease During the COVID-19 Pandemic is not a Responsible Act

Schreiber S, Dignass A, Rogge A, Rubin DT.

Abstract:

Link para artigo

An urgent need to institute COVID-19 testing in patients with IBD experiencing flares

Quraishi MN, Cooney R, Brookes MJ, Sharma N.

Abstract:

Link para artigo

Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19

Vlachoyiannopoulos PG, Magira E, Alexopoulos H, Jahaj E, Theophilopoulou K, Kotanidou A, Tzioufas AG.

Abstract:

Link para artigo

Patient acceptance of using telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak

So H, Szeto CC, Tam LS.

Abstract:

Link para artigo

Telemedicine holds many promises but needs to be developed to be accepted by patients as an alternative to a visit to the doctor. Response to: 'Patient acceptance of using telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak' by So et al

Schulze-Koops H, Specker C, Krueger K.

Abstract:

Link para artigo

From the American Epicenter: Coronavirus Disease 2019 in Patients with Inflammatory Bowel Disease in the New York City Metropolitan Area

Axelrad JE, Malter L, Hong S, Chang S, Bosworth B, Hudesman D.

Abstract:

Link para artigo

Treatment adherence behaviours in rheumatic diseases during COVID-19 pandemic: a Latin American experience

Pineda-Sic RA, Galarza-Delgado DA, Serna-Peña G, Castillo-Torres SA, Flores-Alvarado DE, Esquivel-Valerio JA, Hernández-Galarza IJ.

Abstract:

Link para artigo

Actions required to assure continuous supply of anti-rheumatic medication during the SARS-CoV-2/COVID-19 pandemic. Response to: 'Treatment adherence behaviours in rheumatic diseases during pandemic COVID-19: a Latin American experience' by Pineda-Sic et al

Schulze-Koops H, Krueger K, Specker C; Kommission Pharmakotherapie of the German Society of Rheumatology.

Abstract:

Link para artigo

Adherence of infusible biologics during the time of COVID-19 among patients with Inflammatory Bowel Disease: A nationwide VA cohort study

Khan N, Patel D, Xie D, Pernes T, Lewis J, Yang YX.

Abstract:

Link para artigo

The psychological state and changes in the routine of the patients with rheumatic diseases during the coronavirus disease (COVID-19) outbreak in Turkey: a web-based cross-sectional survey

Seyahi E, Poyraz BC, Sut N, Akdogan S, Hamuryudan V.

Abstract:

Link para artigo

Psoriasis and COVID-19: a multifactorial consideration

Cohen JM, Perez-Chada LM, De Kouchkovsky D, Gehlhausen JR.

Abstract:

Link para artigo

Clinical management of psoriasis patients during the COVID-19 pandemic

Chat VS, Uppal SK, Kearns DG, Wu JJ.

Abstract:

Link para artigo

A cross-sectional survey on the psychological impact of the COVID-19 pandemic on inflammatory bowel disease patients in Saudi Arabia

Mosli M, Alourfi M, Alamoudi A, Hashim A, Saadah O, Al Sulais E, AlAmeel T, Alharbi O, Bakari S, Meeralam Y, Alshobai S, Alsahafi M, Jawa H, Qari Y.

Abstract:

Link para artigo

COVID-19: Overview of Rheumatology Fellows

Garcia-Guillén A, Jeria S, Lobo-Prat D, Sainz L.

Abstract:

Link para artigo

Inflammatory Bowel Disease in the COVID-19 Pandemic - the Patients' Perspective

Grunert PC, Reuken PA, Stallhofer J, Teich N, Stallmach A.

Abstract:

Link para artigo

Autoinflammatory and autoimmune conditions at the crossroad of COVID-19

Rodríguez Y, Novelli L, Rojas M, De Santis M, Acosta-Ampudia Y, Monsalve DM, Ramírez-Santana C, Costanzo A, Ridgway WM, Ansari AA, Gershwin ME, Selmi C, Anaya JM.

Abstract:

Link para artigo

A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab

Cai S, Sun W, Li M, Dong L.

Abstract:

Link para artigo

COVID-19 revisiting inflammatory pathways of arthritis

Schett G, Manger B, Simon D, Caporali R.

Abstract:

Link para artigo

Mounting data indicate that antimalarials do not prevent mild or severe COVID-19 in rheumatic patients. Response to: 'The role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients' by Favalli et al

Rom√£o VC, Cruz-Machado AR, Fonseca JE.

Abstract:

Link para artigo

Role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients

Favalli EG, De Lucia O, Biggioggero M, Del Papa N, Caporali R.

Abstract:

Link para artigo

Challenges and opportunities in telerheumatology in the COVID-19 era. Response to: 'Online management of rheumatoid arthritis during COVID-19 pandemic' by Zhang et al

Figueroa-Parra G, Gamboa-Alonso CM, Galarza-Delgado DA.

Abstract:

Link para artigo

''Treatment adherence in psoriatic patients during COVID-19 pandemic: Real-world data from a tertiary hospital in Greece''

Vakirlis AE, Bakirtzi K, Papadimitriou I, Vrani F, Sideris N, Lallas A, Ioannides D, Sotiriou E.

Abstract:

Link para artigo

Complicated coronavirus disease 2019 (COVID-19) in a psoriatic patient treated with ixekizumab

Facheris P, Valenti M, Pavia G, Gargiulo L, Narcisi A, Costanzo A, Borroni RG.

Abstract:

Link para artigo

SEVERE IBD FLARES AND COVID-19: EXPAND THE GASTROENTEROLOGY-SURGERY TEAM TO INCLUDE AN INFECTIOUS DISEASE SPECIALIST

Bezzio C, Saibeni S.

Abstract:

Link para artigo

Impact of medication discontinuation on patients with inflammatory bowel disease during the COVID-19 outbreak

Chen J, Peng X, Zhang M, Zhi M.

Abstract:

Link para artigo

Prevention of COVID-19 in patients with IBD - Authors' reply

Ding NS, An P, Dong W, Ding Y.

Abstract:

Link para artigo

COVID-19 in patients with rheumatological diseases treated with anti-TNF

Brito CA, Paiva JG, Pimentel FN, Guimar√£es RS, Moreira MR.

Abstract:

Link para artigo

Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China 'hot pot' versus in US 'hot pot': similarity and difference

Zhao J, Pang R, Wu J, Guo Y, Yang Y, Zhang L, Xia X.

Abstract:

Link para artigo

Response to: 'COVID-19 in patients with rheumatological diseases treated with Anti-TNF' by Brito et al and 'Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China 'hot pot' versus in US 'hot pot': similarity and difference' by Zhao et al

D'Silva KM, Serling-Boyd N, Wallwork R, Hsu T, Sparks JA, Wallace ZS.

Abstract:

Link para artigo

Clinical characteristics of 17 patients with COVID-19 and systemic autoimmune diseases: a retrospective study

Huang Y, Chen Z, Wang Y, Han L, Qin K, Huang W, Huang Y, Wang H, Shen P, Ba X, Lin W, Dong H, Zhang M, Tu S.

Abstract:

Link para artigo

Psoriasis and risk of the COVID-19 infection: Is there a role for Angiotensin Converting Enzyme (ACE)?

Shahidi-Dadras M, Tabary M, Robati RM, Araghi F, Dadkhahfar S.

Abstract:

Link para artigo

COVID-19 infection associated with autoimmune hemolytic anemia

Capes A, Bailly S, Hantson P, Gerard L, Laterre PF.

Abstract:

Link para artigo

[Effectiveness of the contingency plan of the internal inflammatory disease unit before Covid-19 infection.]

Carpio López D, Martínez Pillado M, Salgado Barreira Á, Daponte Angueira S, Díez Lage R, Castro Ortiz E, Fernández Salgado E, Pérez Galindo P, Turnes Vázquez J.

Abstract:

Link para artigo

Immune monitoring of a child with autoimmune hepatitis and type 1 diabetes during COVID-19 infection

Yuksel M, Akturk H, Arikan C.

Abstract:

Link para artigo

Aspects of inflammatory bowel disease during the COVID-19 pandemic and general considerations

de León-Rendón JL, Hurtado-Salazar C, Yamamoto-Furusho JK.

Abstract:

Link para artigo

Comment on "Psoriasis, COVID-19 and acute respiratory distress syndrome: focusing on the risk of concomitant biological treatment"

Farabi B, Bhargava S, Goldust M, Atak MF.

Abstract:

Link para artigo

Molecular mimicry may explain multi-organ damage in COVID-19

Angileri F, Legare S, Gammazza AM, de Macario EC, Macario AJL, Cappello F.

Abstract:

Link para artigo

Covid-19 and autoimmunity

Ehrenfeld M, Tincani A, Andreoli L, Cattalini M, Greenbaum A, Kanduc D, Alijotas-Reig J, Zinserling V, Semenova N, Amital H, Shoenfeld Y.

Abstract:

Link para artigo

Cutaneous autoimmune diseases during COVID 19 pandemic

Günther C, Aschoff R, Beissert S.

Abstract:

Link para artigo

Targeting the immunology of coronavirus disease-19: synchronization creates symphony

Ahmed S, Anirvan P.

Abstract:

Link para artigo

Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases

Pablos JL, Abasolo L, Alvaro-Gracia JM, Blanco FJ, Blanco R, Castrejón I, Fernandez-Fernandez D, Fernandez-Gutierrez B, Galindo-Izquierdo M, Gonzalez-Gay MA, Manrique-Arija S, Mena Vázquez N, Mera Varela A, Retuerto M, Seijas-Lopez A.

Abstract:

Link para artigo

Inflammatory Bowel Disease and COVID-19-"Preventive" Sick Certificates as a Frequent Coping Strategy in the Face of the Pandemic

Schlabitz F, Teich N, Michl P, Walldorf J.

Abstract:

Link para artigo

How did COVID-19 pandemic changed the Portuguese rheumatology?

Vieira-Sousa E, Fonseca JE, Santos MJ.

Abstract:

Link para artigo

SFED recommendations for IBD endoscopy during COVID-19 pandemic: Italian and French experience

Furfaro F, Vuitton L, Fiorino G, Koch S, Allocca M, Gilardi D, Zilli A, D'Amico F, Radice S, Chevaux JB, Schaefer M, Chaussade S, Danese S, Peyrin-Biroulet L.

Abstract:

Link para artigo

Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort

Pouletty M, Borocco C, Ouldali N, Caseris M, Basmaci R, Lachaume N, Bensaid P, Pichard S, Kouider H, Morelle G, Craiu I, Pondarre C, Deho A, Maroni A, Oualha M, Amoura Z, Haroche J, Chommeloux J, Bajolle F, Beyler C, Bonacorsi S, Carcelain G, Koné-Paut I, Bader-Meunier B, Faye A, Meinzer U, Galeotti C, Melki I.

Abstract:

Link para artigo

Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort

Costa L, Tasso M, Scotti N, Mostacciuolo E, Girolimetto N, Foglia F, Del Puente A, Scarpa R, Caso F.

Abstract:

Link para artigo

Response to: 'Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort' by Costa et al

Gupta L, Misra DP, Agarwal V, Balan S, Agarwal V.

Abstract:

Link para artigo

Digital crowdsourcing: unleashing its power in rheumatology

Krusche M, Burmester GR, Knitza J.

Abstract:

Link para artigo

SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients

Zen M, Fuzzi E, Astorri D, Saccon F, Padoan R, Ienna L, Cozzi G, Depascale R, Zanatta E, Gasparotto M, Benvenuti F, Bindoli S, Gatto M, Felicetti M, Ortolan A, Campaniello D, Larosa M, Lorenzin M, Ramonda R, Sfriso P, Schiavon F, Iaccarino L, Doria A.

Abstract:

Link para artigo

Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concerns

Festa S, Aratari A, De Biasio F, Fascì-Spurio F, Papi C.

Abstract:

Link para artigo

Fecal Calprotectin and RT-PCR from both nasopharyngeal swab and stool samples prior to treatment decision in IBD patients during CoVID-19 outbreak

Younes C.

Abstract:

Link para artigo

Perspectives of patients with rheumatic diseases in the early phase of COVID-19

Antony A, Connelly K, De Silva T, Eades L, Tillett W, Ayoub S, Morand E.

Abstract:

Link para artigo

COVID-19 era: A chance to learn something new about monitoring psoriatic patients in biological therapy

Filippi F, Loi C, Evangelista V, Bardazzi F.

Abstract:

Link para artigo

Biologics, spondylitis and COVID-19

Rosenbaum JT, Hamilton H, Choi D, Weisman MH, Reveille JD, Winthrop KL.

Abstract:

Link para artigo

Covid-19 and inflammatory bowel disease: questions on incidence, severity, and impact of treatment?

Caron B, Arondel Y, Reimund JM.

Abstract:

Link para artigo

Risk of Severe COVID-19 in Patients with Inflammatory Bowel Disease in United States. A Multicenter Research Network Study

Singh S, Khan A, Chowdhry M, Bilal M, Kochhar GS, Clarke K.

Abstract:

Link para artigo

Managing Psoriasis Consultations During the COVID-19 Pandemic: Recommendations from the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (AEDV)

Belinchón I, Puig L, Ferrándiz L, De La Cueva P, Carrascosa JM; en nombre del Grupo de Psoriasis de la AEDV.

Abstract:

Link para artigo

Safety of drugs during previous and current coronavirus pandemics: Lessons for IBD

Sebastian S, Gonzalez HA, Peyrin-Biroulet L.

Abstract:

Link para artigo

Clinical trials for inflammatory bowel disease: a global guidance during COVID-19 pandemic

Reinisch W, Danese S, Peyrin-Biroulet L, Loftus EV.

Abstract:

Link para artigo

A COVID-19 pneumonia case report of autoimmune polyendocrine syndrome type 1 in Lombardy, Italy: letter to the editor

Beccuti G, Ghizzoni L, Cambria V, Codullo V, Sacchi P, Lovati E, Mongodi S, Iotti GA, Mojoli F.

Abstract:

Link para artigo

Rheumatologists rapidly adjust patient care during COVID-19 pandemic

Kirby T.

Abstract:

Link para artigo

Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases

Dos Reis Neto ET, Kakehasi AM, de Medeiros Pinheiro M, Ferreira GA, Marques CDL, da Mota LMH, Dos Santos Paiva E, Pileggi GCS, Sato EI, Reis APMG, Xavier RM, Provenza JR.

Abstract:

Link para artigo

Temporal Improvement of a COVID-19-Positive Crohn's Disease Patient Treated With Bismuth Subsalicylate

Wolf DC, Wolf CH, Rubin DT.

Abstract:

Link para artigo

[The treatment of inflammatory bowel disease during the SARS-CoV-2 epidemic – practical advices: (A COVID–19-pandémia orvosszakmai kérdései)]

Resál T, Rutka M, Szántó K, Farkas K, Molnár T.

Abstract:

Link para artigo

Covid-19: Was Rheumapatienten jetzt wissen sollten : Handlungsempfehlungen der DGRh

Kraus D.

Abstract:

Link para artigo

Management of pediatric rheumatic patients in Kazakhstan during the coronavirus disease 2019 (COVID-19) pandemic

Mukusheva Z, Assylbekova M, Poddighe D.

Abstract:

Link para artigo

Rheumatologists and Pulmonologists at Temple University weather the COVID-19 storm together

Caricchio R, Criner GJ.

Abstract:

Link para artigo

Teamwork, A Novel Concept During an Infectious Pandemic?

Cron RQ, Chatham WW.

Abstract:

Link para artigo

Response to: 'Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak' by Holubar et al

Mathian A, Amoura Z.

Abstract:

Link para artigo

Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak

Holubar J, Le Quintrec M, Letaief H, Faillie JL, Pers YM, Jorgensen C.

Abstract:

Link para artigo

COVID-19 in rheumatic disease patients on immunosuppressive agents

Sharmeen S, Elghawy A, Zarlasht F, Yao QP.

Abstract:

Link para artigo

Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients

Sawalha AH, Zhao M, Coit P, Lu Q.

Abstract:

Link para artigo

Critically ill SARS-CoV-2 patients display lupus-like hallmarks of extrafollicular B cell activation

Woodruff M, Ramonell R, Cashman K, Nguyen D, Ley A, Kyu S, Saini A, Haddad N, Chen W, Howell JC, Ozturk T, Lee S, Estrada J, Morrison-Porter A, Derrico A, Anam F, Wu H, Le S, Jenks S, Hu W, Lee FE, Sanz I.

Abstract:

Link para artigo

Reduced expression of COVID-19 host receptor, ACE2 is associated with small bowel inflammation, more severe disease, and response to anti-TNF therapy in Crohn's disease

Potdar AA, Dube S, Naito T, Botwin G, Haritunians T, Li D, Yang S, Bilsborough J, Denson LA, Daly M, Targan SR, Fleshner P, Braun J, Kugathasan S, Stappenbeck TS, McGovern DPB.

Abstract:

Link para artigo

COVID-19 and Its Potential Effect on Patients With Rheumatic Diseases in Latin America

Elera-Fitzcarrald C, Ugarte-Gil MF, Alarcón GS.

Abstract:

Link para artigo

Status of a real-life cohort of patients with moderate-to-severe plaque psoriasis treated with secukinumab and considerations on the use of biological agents in the Covid-19 era

Galluzzo M, Tofani L, Bianchi L, Talamonti M.

Abstract:

Link para artigo

Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data?

Favalli EG, Monti S, Ingegnoli F, Balduzzi S, Caporali R, Montecucco C.

Abstract:

Link para artigo

Cutaneous lupus erythematosus patients in a high-epidemic COVID-19 area, Bergamo, Italy

Vezzoli P, Di Mercurio M, Carugno A, Gambini DM, Robustelli Test E, Imberti G, Castagna AF, Sena P.

Abstract:

Link para artigo

Adopting PROs in virtual and outpatient management of RA

Taylor PC.

Abstract:

Link para artigo

COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases

López-Medina C, Escudero A, Collantes-Estevez E.

Abstract:

Link para artigo

Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies

Sanchez-Piedra C, Diaz-Torne C, Manero J, Pego-Reigosa JM, Rúa-Figueroa Í, Gonzalez-Gay MA, Gomez-Reino J, Alvaro-Gracia JM; BIOBADASER study group.

Abstract:

Link para artigo

Telemedicine: a useful tool but not the holy grail. Response to: 'Telemedicine will not keep us apart in the COVID-19 pandemic' by Perniola et al

Bozzalla Cassione E, Zanframundo G, Biglia A, Codullo V, Montecucco C, Cavagna L.

Abstract:

Link para artigo

Candidate rheumatologic treatments for COVID-19. Response to: 'COVID-19 infection in a patient with FMF: does colchicine have a protective effect?' by Kobak

Monti S, Montecucco C.

Abstract:

Link para artigo

EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2

Landewé RB, Machado PM, Kroon F, Bijlsma HW, Burmester GR, Carmona L, Combe B, Galli M, Gossec L, Iagnocco A, Isaacs JD, Mariette X, McInnes I, Mueller-Ladner U, Openshaw P, Smolen JS, Stamm TA, Wiek D, Schulze-Koops H.

Abstract:

Link para artigo

COVID-19 infection in a patient with FMF: does colchicine have a protective effect?

Kobak S.

Abstract:

Link para artigo

Telemedicine will not keep us apart in COVID-19 pandemic

Perniola S, Alivernini S, Varriano V, Paglionico A, Tanti G, Rubortone P, Lanzo L, Melpignano F, Tur C, De Lorenzis E, Peluso G, Capacci A, Gremese E.

Abstract:

Link para artigo

Response to: 'COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases' by Lopez-Medina et al

Bozzalla Cassione E, Zanframundo G, Biglia A, Codullo V, Montecucco C, Cavagna L.

Abstract:

Link para artigo

Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab

Avouac J, Airó P, Carlier N, Matucci-Cerinic M, Allanore Y.

Abstract:

Link para artigo

Response to: 'Severe COVID-19 associated pneumonia in 3 patients with systemic sclerosis treated with rituximab' by Avouac et al

Guilpain P, Le Bihan C, Foulongne V, Taourel P, Pansu N, Maria ATJ, Jung B, Larcher R, Klouche K, Le Moing V.

Abstract:

Link para artigo

The association between severe or death COVID-19 and autoimmune disease: a systematic review and meta-analysis

Liu M, Gao Y, Zhang Y, Shi S, Chen Y, Tian J.

Abstract:

Link para artigo

Rheumatic diseases during pregnancy and SARS-CoV-2: An appeal for medication adherence

Scioscia M, Praino E, Scioscia C.

Abstract:

Link para artigo

Psoriasis-COVID 19 Infection: Treatment Options

Tampouratzi E, Kanni T, Katsantonis J, Douvali T.

Abstract:

Link para artigo

Implications of COVID-19 in pediatric rheumatology

Batu ED, Özen S.

Abstract:

Link para artigo

Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy-a case report

Hu Z, Chen W, Liang W, Xu C, Sun W, Yi Y.

Abstract:

Link para artigo

Autoimmune and inflammatory diseases following COVID-19

Galeotti C, Bayry J.

Abstract:

Link para artigo

Combination of thrombolytic and immunosuppressive therapy for coronavirus disease 2019: A case report

Papamichalis P, Papadogoulas A, Katsiafylloudis P, Skoura AL, Papamichalis M, Neou E, Papadopoulos D, Karagiannis S, Zafeiridis T, Babalis D, Komnos A.

Abstract:

Link para artigo

Author´s answer to: "Effect of adacolumn® in ulcerative colitis with COVID-19"

Hinojosa Del Val J, Crespo J, Pérez-Cuadrado Martínez E.

Abstract:

Link para artigo

The effect of Adacolumn® on ulcerative colitis with COVID-19

Pérez Roldán F, Bernardos Martín ME, González Carro P.

Abstract:

Link para artigo

Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: Results From a National Survey

Martin Arranz E, Suarez Ferrer C, García Ramírez L, Rueda García JL, Sánchez-Azofra M, Poza Cordón J, Noci J, Zabana Y, Barreiro-de Acosta M, Martín-Arranz MD.

Abstract:

Link para artigo

COVID-19 presenting with autoimmune hemolytic anemia in the setting of underlying immune dysregulation

Wahlster L, Weichert-Leahey N, Trissal M, Grace RF, Sankaran VG.

Abstract:

Link para artigo

COVID-19 in rheumatology outpatient clinics: Dutch mirror image to Lombardy, Italy

Benoy S, Traksel R, Verhaegh P, Broen J.

Abstract:

Link para artigo

Self-care recommendations for patients with rheumatic diseases during the COVID-19 pandemic

Kim HS, Lee MS, Kim H, Sung YK, Lee J, Shim SC, Park SH, Baek HJ.

Abstract:

Link para artigo

Cranial Neuropathies and COVID-19: Neurotropism and Autoimmunity

Costello F, Dalakas MC.

Abstract:

Link para artigo

The day after COVID-19 in IBD: how to go back to 'normal'

Danese S, Sands B, Ng SC, Peyrin-Biroulet L.

Abstract:

Link para artigo

Are patients with systemic lupus erythematosus at increased risk of severe COVID-19?

Favalli EG, Agape E, Caporali R.

Abstract:

Link para artigo

No SLE with COVID-19 in Hong Kong: the effect of masking?

So H, Mak JWY, Tam LS.

Abstract:

Link para artigo

Implementing telemedicine in inflammatory bowel disease: Is COVID-19 the definitive trigger?

Del Hoyo J, Aguas M.

Abstract:

Link para artigo

Rates of symptomatic SARS-CoV-2 infection in patients with autoimmune liver diseases in Northern Italy: a telemedicine study

Rigamonti C, Cittone MG, De Benedittis C, Rizzi E, Casciaro GF, Bellan M, Sainaghi PP, Pirisi M.

Abstract:

Link para artigo

Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients with Inflammatory Bowel Disease

Lukin DJ, Kumar A, Hajifathalian K, Sharaiha RZ, Scherl EJ, Longman RS; JRC Study Group; WCM-GI Study Group.

Abstract:

Link para artigo

Psoriatic Arthritis and COVID-19 Pandemic: Consequences in Medical Treatment?

Wollina U, Fioranelli M, Goldust M, Lotti T.

Abstract:

Link para artigo

Covid-19 infection in psoriasis patients treated with cyclosporin

Di Lernia V, Goldust M, Feliciani C.

Abstract:

Link para artigo

Psoriasis, biologic therapy, and the pandemic of the 21st century

Nogueira M, Vender R, Torres T.

Abstract:

Link para artigo

Olfactory and Gustatory Dysfunction in a COVID-19 Patient with Ankylosing Spondylitis Treated with Etanercept: Case Report

Lee JM, Lee SJ.

Abstract:

Link para artigo

The Greek Response to COVID-19: A True Success Story from an IBD Perspective

Bamias G, Lagou S, Gizis M, Karampekos G, Kyriakoulis KG, Pontas C, Mantzaris GJ.

Abstract:

Link para artigo

Patients with lupus with COVID-19: University of Michigan experience

Wallace B, Washer L, Marder W, Kahlenberg JM.

Abstract:

Link para artigo

Patients with systemic lupus erythematosus using hydroxychloroquine or chloroquine develop severe COVID-19 at similar frequency as patients not on antimalarials: need to explore antithrombotic benefits for COVID-19 coagulopathy. Response to: 'Clinical course of COVID-19 in patients with systemic

Konig MF, Gianfrancesco M, Yazdany J, Robinson PC.

Abstract:

Link para artigo

No advice to discontinue antirheumatic therapy for non-medical reasons in light of SARS-CoV-2. Response to: 'Treatment adherence of patients with sytemic rheumatic diseases in COVID-19 pandemic' by Fragoulis et al

Schulze-Koops H, Krueger K, Specker C.

Abstract:

Link para artigo

Response to: 'Patients with lupus with COVID-19: University of Michigan experience' by Wallace et al

Mathian A, Amoura Z.

Abstract:

Link para artigo

Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine

Carbillon L, Benbara A, Boujenah J.

Abstract:

Link para artigo

Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic

Fragoulis GE, Evangelatos G, Arida A, Bournia VK, Fragiadaki K, Karamanakos A, Kravvariti E, Laskari K, Panopoulos S, Pappa M, Tektonidou MG, Sfikakis PP.

Abstract:

Link para artigo

Rate of Patient-Driven Biologic Treatment Discontinuation During the COVID-19 Pandemic in 2 Academic Hospital Clinics at the University of Toronto

Georgakopoulos JR, Yeung J.

Abstract:

Link para artigo

Patterns of endoscopy during COVID-19 pandemic: a global survey of interventional inflammatory bowel disease practice

Chen Y, Yu Q, Farraye FA, Kochhar GS, Bernstein CN, Navaneethan U, Wu K, Zhong J, Schwartz DA, Wu H, Zheng JJ, Iacucci M, Kiran RP, Shen B.

Abstract:

Link para artigo

Psoriasis, COVID-19 and acute respiratory distress syndrome: focusing on the risk of concomitant biological treatment

Magnano M, Balestri R, Bardazzi F, Mazzatenta C, Girardelli CR, Rech G.

Abstract:

Link para artigo

Potential role of Anti-IL-17 in COVID-19 treatment

Ayhan E, Öztürk M, An İ, Abdelmaksoud A, Araç E.

Abstract:

Link para artigo

Clinical efficacy, speed of improvement and safety of apremilast for the treatment of adult Psoriasis during COVID-19 pandemic

Melis D, Mugheddu C, Sanna S, Atzori L, Rongioletti F.

Abstract:

Link para artigo

Non-complicated evolution of COVID-19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab

Valenti M, Facheris P, Pavia G, Gargiulo L, Borroni RG, Costanzo A, Narcisi A.

Abstract:

Link para artigo

Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19?

Vakil-Gilani K, O'Rourke K.

Abstract:

Link para artigo

Switching to teleconsultation for rheumatology in the wake of the COVID-19 pandemic: feasibility and patient response in India

Shenoy P, Ahmed S, Paul A, Skaria TG, Joby J, Alias B.

Abstract:

Link para artigo

Innovation in IBD Care During the COVID-19 Pandemic: Results of a Global Telemedicine Survey by the International Organization for the Study of Inflammatory Bowel Disease

Lees CW, Regueiro M, Mahadevan U; International Organization for the Study of Inflammatory Bowel Disease.

Abstract:

Link para artigo

Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient

Sagnelli C, Gentile V, Tirri R, Macera M, Cappabianca S, Ciccia F; Vanvitelli COVID-19 group.

Abstract:

Link para artigo

Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020

Richez C, Flipo RM, Berenbaum F, Cantagrel A, Claudepierre P, Debiais F, Dieudé P, Goupille P, Roux C, Schaeverbeke T, Wendling D, Pham T, Thomas T.

Abstract:

Link para artigo

COVID 19 and Ethnicity: Spot light on the global rheumatology issues in developing and developed countries

Moorthy A, Dubey S, Samanta A, Adebajo A, Aggarwal A, Jain A, Jain N, Lim SS, Kerr GS, Kumar K.

Abstract:

Link para artigo

Potential inhibition of COVID-19-driven pneumonia by immunosuppressive therapy and anti-TNFα antibodies: a case report

Kunisaki R, Tsukiji J, Kudo M.

Abstract:

Link para artigo

Rheumatology Care in the Face of COVID-19

Lubrano E, Scriffignano S, Perrotta FM.

Abstract:

Link para artigo

COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments

Ouédraogo DD, Tiendrébéogo WJS, Kaboré F, Ntsiba H.

Abstract:

Link para artigo

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, Izadi Z, Jacobsohn L, Katz P, Lawson-Tovey S, Mateus EF, Rush S, Schmajuk G, Simard J, Strangfeld A, Trupin L, Wysham KD, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Wallace ZS, Yazdany J, Machado PM, Robinson PC; COVID-19 Global Rheumatology Alliance.

Abstract:

Link para artigo

Response to: Correspondence regarding research letter to the editor by Mathian et al, 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'' by Nikpour et al

Mathian A, Amoura Z.

Abstract:

Link para artigo

Case series of acute arthritis during COVID-19 admission

López-González MD, Peral-Garrido ML, Calabuig I, Tovar-Sugrañes E, Jovani V, Bernabeu P, García-Sevila R, León-Ramírez JM, Moreno-Perez O, Boix V, Gil J, Merino E, Vela P, Andrés M.

Abstract:

Link para artigo

Correspondence regarding research letter to the editor by Mathian et al, 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'

Nikpour M, Teh B, Wicks IP, Pellegrini M.

Abstract:

Link para artigo

Response to: 'Case series of acute arthritis in COVID-19 admission' by López-González et al

Graef ER, Liew JW, Kim AH, Sparks JA.

Abstract:

Link para artigo

Frequency of lupus anticoagulant in Covid-19 patients

Harzallah I, Debliquis A, Drénou B.

Abstract:

Link para artigo

Novel Coronavirus Disease (COVID-19) and Biologic Therapy for Psoriasis: Successful Recovery in Two Patients After Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Brownstone ND, Thibodeaux QG, Reddy VD, Myers BA, Chan SY, Bhutani T, Liao W.

Abstract:

Link para artigo

Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study

Salvarani C, Bajocchi G, Mancuso P, Galli E, Muratore F, Boiardi L, Catanoso M, Pipitone N, Cassone G, Girolimetto N, Croci S, Cimino L, Gradellini F, Beltrami M, Di Lernia V, Dolci G, Massari M, Marata AM, Costantini M, Giorgi Rossi P.

Abstract:

Link para artigo

Care for patients with rheumatic diseases during COVID-19 pandemic: A position statement from APLAR

Tam LS, Tanaka Y, Handa R, Chang CC, Cheng YK, Isalm N, Li M, Lorenzo JP, Song YW, Yamamoto K, Zeng X, Haq SA.

Abstract:

Link para artigo

Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19

Albiol N, Awol R, Martino R.

Abstract:

Link para artigo

Use of systemic therapies for psoriasis in the COVID-19 era

Kearns DG, Uppal S, Chat VS, Wu JJ.

Abstract:

Link para artigo

Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'

D'Silva KM, Serling-Boyd N, Wallwork R, Hsu T, Fu X, Gravallese EM, Choi HK, Sparks JA, Wallace ZS.

Abstract:

Link para artigo

Two False Negative Test Results in a Symptomatic Patient with a Confirmed Case of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Suspected Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN)

Lagziel T, Quiroga L, Ramos M, Hultman CS, Asif M.

Abstract:

Link para artigo

Pediatric Crohn's Disease and Multisystem Inflammatory Syndrome in Children (MIS-C) and COVID-19 Treated with Infliximab

Dolinger MT, Person H, Smith R, Jarchin L, Pittman N, Dubinsky MC, Lai J.

Abstract:

Link para artigo

COVID-19: the new challenge for rheumatologists. First update

Ferro F, Elefante E, Puxeddu I, Baldini C, Bartoloni E, Baratè C, Galimberti S, Talarico R, Mosca M, Bombardieri S.

Abstract:

Link para artigo

Understanding immune effects of oestrogens to explain the reduced morbidity and mortality in female versus male COVID-19 patients. Comparisons with autoimmunity and vaccination

Cutolo M, Smith V, Paolino S.

Abstract:

Link para artigo

Treating Covid-19 at the Inflection Point

Chatham WW, Cron RQ.

Abstract:

Link para artigo

Evidence of protective effect of hydroxychloroquine to prevent COVID-19

Joob B, Wiwanitkit V.

Abstract:

Link para artigo

Dr. Balevic, et al, reply

Balevic SJ, Hornik CP, Green TP, Clowse MEB, Gonzalez D, Maharaj AR, Schanberg LE, Eudy AM, Swamy GK, Hughes BL, Cohen-Wolkowiez M.

Abstract:

Link para artigo

Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19?' by Favalli et al

Mathian A, Amoura Z.

Abstract:

Link para artigo

Are patients with systemic lupus erythematosus at increased risk for COVID-19?

Favalli EG, Gerosa M, Murgo A, Caporali R.

Abstract:

Link para artigo

IBD in the Times of COVID-19

Hern√°ndez Benabe S, Langshaw AH.

Abstract:

Link para artigo

Impact of delayed diagnoses at the time of COVID-19: increased rate of preventable bilateral blindness in giant cell arteritis

Monti S, Delvino P, Bellis E, Milanesi A, Brandolino F, Montecucco C.

Abstract:

Link para artigo

YouTube as a source of information on COVID-19 and rheumatic disease link

Kocyigit BF, Akaltun MS, Sahin AR.

Abstract:

Link para artigo

Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: a population-based study in the first two months of COVID-19 outbreak in Italy

Quartuccio L, Valent F, Pasut E, Tascini C, Vita S.

Abstract:

Link para artigo

Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China

Ye C, Cai S, Shen G, Guan H, Zhou L, Hu Y, Tu W, Chen Y, Yu Y, Wu X, Chen Y, Zhong J, Dong L.

Abstract:

Link para artigo

Telemedicine for Pediatric Inflammatory Bowel Disease in the Era of COVID-19

Verstraete SG, Sola AM, Ali SA.

Abstract:

Link para artigo

Corona Virus Disease 2019 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology, and Nutrition

Turner D, Huang Y, Martín-de-Carpi J, Aloi M, Focht G, Kang B, Zhou Y, Sanchez C, Kappelman MD, Uhlig HH, Pujol-Muncunill G, Ledder O, Lionetti P, Dias JA, Ruemmele FM, Russell RK; Paediatric IBD Porto group of ESPGHAN.

Abstract:

Link para artigo

Prevention of COVID-19 in patients with IBD

Segal JP, Quraishi MN, Bhala N, Brookes MJ.

Abstract:

Link para artigo

Protecting patients with IBD during the COVID-19 pandemic

Fiorino G, Peyrin-Biroulet L, Danese S.

Abstract:

Link para artigo

A Rare Case of Immune Thrombocytopenic Purpura Secondary to COVID-19

Yang Y, Zhao J, Wu J, Teng Y, Xia X.

Abstract:

Link para artigo

Should we be using the Covid-19 outbreak to prompt us to transform our rheumatology service delivery in the technology age?

Jethwa H, Abraham S.

Abstract:

Link para artigo

Clinical and Psychological Issues in Children with Inflammatory Bowel Disease During COVID-19 Pandemic

Martinelli M, Strisciuglio C, Fedele F, Miele E, Staiano A.

Abstract:

Link para artigo

Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience

Sun Y, Dong Y, Wang L, Xie H, Li B, Chang C, Wang FS.

Abstract:

Link para artigo

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre

Scaldaferri F, Pugliese D, Privitera G, Onali S, Lopetuso LR, Rizzatti G, Settanni CR, Pizzoferrato M, Schiavoni E, Turchini L, Amatucci V, Napolitano D, Bernabei T, Mora V, Laterza L, Papa A, Guidi L, Rapaccini GL, Gasbarrini A, Armuzzi A.

Abstract:

Link para artigo

Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 Pandemic

D'Amico F, Peyrin-Biroulet L, Danese S.

Abstract:

Link para artigo

Response to: 'Hydroxychloroquine shortages during the COVID-19 pandemic' by Mendel et al

McInnes I.

Abstract:

Link para artigo

Rheumatic diseases in intensive care unit patients with COVID-19

Moiseev S, Avdeev S, Brovko M, Yavorovskiy A, Novikov PI, Umbetova K, Akulkina L, Tsareva N, Fomin V.

Abstract:

Link para artigo

Hydroxychloroquine shortages during the COVID-19 pandemic

Mendel A, Bernatsky S, Thorne JC, Lacaille D, Johnson SR, Vinet É.

Abstract:

Link para artigo

Comorbidities and rheumatological diseases at the time of COVID-19. Response to: 'Rheumatic diseases in intensive care unit patients with COVID-19' by Moiseev et al

Monti S, Montecucco C.

Abstract:

Link para artigo

Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander?

Ruscitti P, Berardicurti O, Barile A, Cipriani P, Shoenfeld Y, Iagnocco A, Giacomelli R.

Abstract:

Link para artigo

Should coronavirus disease 2019 concern rheumatologists?

Kucharz EJ.

Abstract:

Link para artigo

Starting a biologic therapy in IBD patients amidst COVID-19: hold, careful monitoring or testing?

Zingone F, Buda A, Savarino EV.

Abstract:

Link para artigo

Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs

Michelena X, Borrell H, López-Corbeto M, López-Lasanta M, Moreno E, Pascual-Pastor M, Erra A, Serrat M, Espartal E, Antón S, Añez GA, Caparrós-Ruiz R, Pluma A, Trallero-Araguás E, Barceló-Bru M, Almirall M, De Agustín JJ, Segura JL, Julià A, Marsal S.

Abstract:

Link para artigo

Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry

Brenner EJ, Ungaro RC, Gearry RB, Kaplan GG, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Ruemmele FM, Steinwurz F, Underwood FE, Zhang X, Colombel JF, Kappelman MD.

Abstract:

Link para artigo

Roles of Clinical Pharmacists in Caring for Patients with Inflammatory Bowel Disease during COVID-19

Bhat S, Farraye FA, Moss A.

Abstract:

Link para artigo

The utility of fecal calprotectin in the era of COVID-19 pandemic

Abstract:

Link para artigo

Opportunistic virus infections in psoriasis patients: the safer alternative of apremilast

Armesto S, González Vela C, González López MA.

Abstract:

Link para artigo

Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?

Erre GL, Ferraccioli ES, Piga M, Mangoni A, Passiu G, Gremese E, Ferraccioli G.

Abstract:

Link para artigo

Response to: 'Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?' by Erre et al

Graef ER, Liew JW, Kim AH, Sparks JA.

Abstract:

Link para artigo

COVID-19 and Rheumatology patients on immunomodulatory therapy - can we extrapolate data from previous viral pandemics?

Jethwa H, Sullivan A, Abraham S.

Abstract:

Link para artigo

Balancing risks and benefits in inflammatory bowel disease patients during the COVID-19 pandemic

Kotze PG, Peyrin-Biroulet L, Danese S.

Abstract:

Link para artigo

Management Strategies of Autoimmune bullous diseases during the Outbreak of 2019 Novel Coronavirus Disease (COVID-19).

Chen P, Zhang G, Zhan Y.

Abstract:

Link para artigo

Evans syndrome in a patient with COVID-19.

Li M, Nguyen CB, Yeung Z, Sanchez K, Rosen D, Bushan S.

Abstract:

Link para artigo

[COVID-19 and inflammatory bowel disease: questions arising from patient care and follow-up during the initial phase of the pandemic (February-April 2020)]

Marín-Jiménez I, Zabana Y, Rodríguez-Lago I, Marín L, Acosta MB, Esteve M; en representación de GETEII y GETECCU.

Abstract:

Link para artigo

Implementing Telemedicine in Inflammatory Bowel Disease: is COVID-19 the definitive trigger?

Hoyo JD, Aguas M.

Abstract:

Link para artigo

Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients

Fortuné C, Gietzen A, Guillot G, Lewis N, Nielsen K, Richard M, Sauvé M, Welling J; SPIN Investigators, Baron M, Furst DE, Gottesman K, Malcarne V, Mayes MD, Mouthon L, Nielson WR, Riggs R, Wigley F, Assassi S, Boutron I, Ells C, van den Ende C, Fligelstone K, Frech T, Godard D, Harel D, Hinchcliff M, Hudson M, Johnson SR, Larche M, Leite C, Nguyen C, Pope J, Portales A, Rannou F, Reyna TSR, Schouffoer AA, Suarez-Almazor ME, Agard C, Albert A, André M, Arsenault G, Benzidia I, Bernstein EJ, B

Abstract:

Link para artigo

The risk of respiratory tract infections and symptoms in psoriasis patients treated with IL-17-pathway inhibiting biologics: A meta-estimate of pivotal trials relevant to decision-making during the COVID-19 pandemic

Wan MT, Shin DB, Winthrop KL, Gelfand JM.

Abstract:

Link para artigo

COVID-19 knowledge prevents biologics discontinuation: data from an Italian multi-center survey during RED-ZONE declaration.

Bragazzi NL, Riccò M, Pacifico A, Malagoli P; COVID19 Dermatological Task Force, Young Dermatologists Italian Network., Kridin K, Pigatto P, Damiani G.

Abstract:

Link para artigo

Disability and quality of life before and during the COVID-19 outbreak: A cross-sectional study in inflammatory bowel disease patients

Azzam NA, Aljebreen A, Almuhareb A, Almadi MA.

Abstract:

Link para artigo

Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs' by Conticini et al.

Monti S, Montecucco C.

Abstract:

Link para artigo

COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs.

Conticini E, Bargagli E, Bardelli M, Rana GD, Baldi C, Cameli P, Gentileschi S, Bennett D, Falsetti P, Lanzarone N, Bellisai F, Barreca C, D'Alessandro R, Cantarini L, Frediani B.

Abstract:

Link para artigo

Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids.

Abstract:

Link para artigo

Health status of patients with Autoimmune Liver Disease during SARS-CoV-2 outbreak in northern Italy.

Abstract:

Link para artigo

Patterns of care for inflammatory bowel disease in China during the COVID-19 pandemic.

Abstract:

Link para artigo

Views of patients with inflammatory bowel disease on the COVID-19 pandemic: a global survey.

Abstract:

Link para artigo

COVID-19 with rheumatic diseases: a report of 5 cases.

Cheng C, Li C, Zhao T, Yue J, Yang F, Yan Y, Liu X.

Abstract:

Link para artigo

COVID-19 and your rheumatology patients.

Calabrese C.

Abstract:

Link para artigo

Excessive anxiety in IBD patients is unnecessary for COVID-19.

Abstract:

Link para artigo

Keeping on the high quality of healthcare in Greek Inflammatory Bowel Disease patients in the SARS-CoV-2 era.

Abstract:

Link para artigo

Could Patients With Inflammatory Bowel Disease Treated with Immunomodulators or Biologics Be at Lower Risk for Severe Forms of Covid-19?

Abstract:

Link para artigo

Impact of COVID-19 outbreak on the management of patients with severe IBD: a domino effect.

Abstract:

Link para artigo

Experience of a second-level Rheumatology Clinic during the Covid-19 quarantine.

Colaci M, Aprile ML, Sambataro D, Sambataro G, Malatino L.

Abstract:

Link para artigo

A survey of psoriasis patients on biologics during COVID-19: a single centre experience.

Burlando M, Carmisciano L, Cozzani E, Parodi A.

Abstract:

Link para artigo

Tocilizumab: From the Rheumatology Practice to the Fight Against COVID-19, a virus infection with multiple faces.

González-Gay MA, Mayo J, Castañeda S, Cifrián JM, Hernández-Rodríguez J.

Abstract:

Link para artigo

Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic.

Benson-Pope SJ, Gearry RB.

Abstract:

Link para artigo

Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic-authors' reply.

King DS, Trudgill NJ, Adderley NJ.

Abstract:

Link para artigo

COVID-19 with rheumatic diseases: a report of 5 cases.

Cheng C, Li C, Zhao T, Yue J, Yang F, Yan Y, Liu X.

Abstract:

Link para artigo

Response to: 'Patients with lupus are not protected from COVID-19: a comment' by Sawalha, 'No evidence so far on the protective effect of hydroxycloroquin to prevent COVID-19: response to the Comment by Joob and Wiwanitkit' by Rom√£o et al and 'SLE patients are not immune to COVID-19: importance of s...

Joob B, Wiwanitkit V.

Abstract:

Link para artigo

How to Effectively Support Patients with Rheumatic Conditions Now and Beyond COVID-19.

Décary S, Barton JL, Proulx L, Richards DP, Paterson G, de Wit M, Toupin-April K.

Abstract:

Link para artigo

COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.

Bozzalla Cassione E, Zanframundo G, Biglia A, Codullo V, Montecucco C, Cavagna L.

Abstract:

Link para artigo

Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature.

Rosen MH, Axelrad J, Hudesman D, Rubin DT, Chang S.

Abstract:

Link para artigo

Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials.

Balevic SJ, Hornik CP, Green TP, Clowse MEB, Gonzalez D, Maharaj AR, Schanberg LE, Eudy AM, Swamy GK, Hughes BL, Cohen-Wolkowiez M.

Abstract:

Link para artigo

Keeping lupus patients on hydroxychloroquine during the COVID-19 pandemic.

Littlejohn E.

Abstract:

Link para artigo

COVID-19 in Patients with Myasthenia Gravis.

Anand P, Slama MCC, Kaku M, Ong C, Cervantes-Arslanian AM, Zhou L, David WS, Guidon AC.

Abstract:

Link para artigo

Inflammatory bowel disease and the SARS-CoV-2 pandemic: more speed, less haste.

Abstract:

Link para artigo

Capturing patient-reported outcomes during the COVID-19 pandemic: Development of the COVID-19 Global Rheumatology Alliance Patient Experience Survey.

Sirotich E, Dillingham S, Grainger R, Hausmann JS; COVID-19 Global Rheumatology Alliance Steering Committee..

Abstract:

Link para artigo

Inflammatory Bowel Diseases and Biological Treatment in SARS-CoV-2 Era. Why Not?

Grassia R, Soro S, Conti CB.

Abstract:

Link para artigo

COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management.

Mugheddu C, Pizzatti L, Sanna S, Atzori L, Rongioletti F.

Abstract:

Link para artigo

Anti-TNF-α Agents in Inflammatory Bowel Disease and Course of COVID-19.

Tursi A, Vetrone LM, Papa A.

Abstract:

Link para artigo

Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.

Konig MF, Kim AH, Scheetz MH, Graef ER, Liew JW, Simard J, Machado PM, Gianfrancesco M, Yazdany J, Langguth D, Robinson PC; COVID-19 Global Rheumatology Alliance..

Abstract:

Link para artigo

Challenges in chronic paediatric disease during the COVID-19 pandemic: diagnosis and management of inflammatory bowel disease in children.

Ashton JJ, Batra A, Coelho TAF, Afzal NA, Beattie RM.

Abstract:

Link para artigo

Response to "Lupus anticoagulant is frequent in patients with Covid-19".

Tang N.

Abstract:

Link para artigo

Improvement of SARS-CoV2 symptoms following Guselkumab injection in a psoriatic patient.

Benhadou F, Del Marmol V.

Abstract:

Link para artigo

Coagulopathy of COVID-19 and antiphospholipid antibodies.

Connell NT, Battinelli EM, Connors JM.

Abstract:

Link para artigo

Evolution of COVID-19 infection in 4 psoriatic patients treated with biological drugs.

Conti A, Lasagni C, Bigi L, Pellacani G.

Abstract:

Link para artigo

Widening Disparities Among Patients with Rheumatic Diseases in the COVID-19 Era: An Urgent Call to Action.

Feldman CH, Ramsey-Goldman R.

Abstract:

Link para artigo

Author Correction: Management of IBD during the COVID-19 outbreak: resetting clinical priorities.

Danese S, Cecconi M, Spinelli A.

Abstract:

Link para artigo

Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series.

Aouba A, Baldolli A, Geffray L, Verdon R, Bergot E, Martin-Silva N, Justet A.

Abstract:

Link para artigo

Autoimmune hemolytic anemia associated with Covid-19 infection.

Lazarian G, Quinquenel A, Bellal M, Siavellis J, Jacquy C, Re D, Merabet F, Mekinian A, Braun T, Damaj G, Delmer A, Cymbalista F.

Abstract:

Link para artigo

COVID-19: an unexpected indication for anti-rheumatic therapies?

Lucchino B, Di Franco M, Conti F.

Abstract:

Link para artigo

The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance.

Wallace ZS, Bhana S, Hausmann JS, Robinson PC, Sufka P, Sirotich E, Yazdany J, Grainger R.

Abstract:

Link para artigo

Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2 - exploring RAS inhibitors.

Garg M, Royce SG, Lubel JS.

Abstract:

Link para artigo

Practical Advice for Management of IBD Patients during the COVID-19 Pandemic: A World Endoscopy Organization Statement.

Neumann H, Emura F, Bokemeyer B, Guda N, Tajiri H, Matsumoto T, Rubin DT.

Abstract:

Link para artigo

Simultaneous Onset of COVID-19 and Autoimmune Hemolytic Anemia.

Lopez C, Kim J, Pandey A, Huang T, DeLoughery TG.

Abstract:

Link para artigo

Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.

Bowles L, Platton S, Yartey N, Dave M, Lee K, Hart DP, MacDonald V, Green L, Sivapalaratnam S, Pasi KJ, MacCallum P.

Abstract:

Link para artigo

Response to 'To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic' by Parperis.

Spinelli FR, Ceccarelli F, Di Franco M, Conti F.

Abstract:

Link para artigo

Going Viral: Management of IBD in the Era of the COVID-19 Pandemic.

Gutin LS, Lam AY, Velayos FS, Santos SA.

Abstract:

Link para artigo

2019 Novel Coronavirus Disease (COVID-19) in patients with Inflammatory Bowel Diseases.

Taxonera C, Sagastagoitia I, Alba C, Mañas N, Olivares D, Rey E.

Abstract:

Link para artigo

Comment on "Antipsoriatic treatments during COVID-19 outbreak".

Abdelmaksoud A, Goldust M, Vestita M.

Abstract:

Link para artigo

Biologic therapy for psoriasis during the COVID-19 outbreak: the choice is to weigh risks and benefits.

Conforti C, Giuffrida R, Dianzani C, Di Meo N, Zalaudek I.

Abstract:

Link para artigo

SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor.

Balestri R, Rech G, Girardelli CR.

Abstract:

Link para artigo

Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemic.

Price E, MacPhie E, Kay L, Lanyon P, Griffiths B, Holroyd C, Abhishek A, Youngstein T, Bailey K, Clinch J, Shaikh M, Rivett A.

Abstract:

Link para artigo

Biologics increase the risk of SARS- CoV-2 infection and hospitalization, but not ICU admission and death: real-life data from a large cohort during RED-ZONE declaration.

Damiani G, Pacifico A, Bragazzi NL, Malagoli P.

Abstract:

Link para artigo

What Does the COVID-19 Pandemic Mean for Rheumatology Patients?

Pope JE.

Abstract:

Link para artigo

Combating physical inactivity during the COVID-19 pandemic.

Pinto AJ, Dunstan DW, Owen N, Bonf√° E, Gualano B.

Abstract:

Link para artigo

Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study.

Bezzio C, Saibeni S, Variola A, Allocca M, Massari A, Gerardi V, Casini V, Ricci C, Zingone F, Amato A, Caprioli F, Lenti MV, Viganò C, Ascolani M, Bossa F, Castiglione F, Cortelezzi C, Grossi L, Milla M, Morganti D, Pastorelli L, Ribaldone DG, et al.

Abstract:

Link para artigo

Non-steroidal anti-inflammatory treatment during covid-19: friend or foe? Response to: 'Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)' by Giollo et al.

Monti S, Montecucco C.

Abstract:

Link para artigo

Diagnostic and therapeutic challenges for patients with ANCA-associated vasculitides at the time of COVID-19. Response to: 'Rituximab for granulomatosis with polyangiitis in the pandemic of COVID-19: lessons from a case with severe pneumonia' by Guilpain et al.

Monti S, Montecucco C.

Abstract:

Link para artigo

Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept.

Duret PM, Sebbag E, Mallick A, Gravier S, Spielmann L, Messer L.

Abstract:

Link para artigo

Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States.

Aggarwal S, Garcia-Telles N, Aggarwal G, Lavie C, Lippi G, Henry BM.

Abstract:

Link para artigo

Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management.

Matucci-Cerinic M, Bruni C, Allanore Y, Clementi M, Dagna L, Damjanov NS, de Paulis A, Denton CP, Distler O, Fox D, Furst DE, Khanna D, Krieg T, Kuwana M, Lee EB, Li M, Pillai S, Wang Y, Zeng X, Taliani G.

Abstract:

Link para artigo

American College of Rheumatology Guidance for the Management of Adult Patients with Rheumatic Disease During the COVID-19 Pandemic.

Mikuls TR, Johnson SR, Fraenkel L, Arasaratnam RJ, Baden LR, Bermas BL, Chatham W, Cohen S, Costenbader K, Gravallese EM, Kalil AC, Weinblatt ME, Winthrop K, Mudano AS, Turner A, Saag KG.

Abstract:

Link para artigo

Ambulatory Management of perianal Crohn's Disease during the Covid-19 Pandemic.

Andrea D, Bruno S, Giuseppe S.

Abstract:

Link para artigo

Review Article: Prevention, Diagnosis and Management of COVID-19 in the Inflammatory Bowel Disease Patient.

Al-Ani A, Prentice R, Rentsch C, Johnson D, Ardalan Z, Heerasing N, Garg M, Campbell S, Sasadeusz J, Macrae F, Ng SC, Rubin DT, Christensen B.

Abstract:

Link para artigo

Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic.

Mahil SK, Yiu ZZN, Mason KJ, Dand N, Coker B, Wall D, Fletcher G, Bosma A, Capon F, Iversen L, Langan SM, Di Meglio P, Musters A, Prieto-Merino D, Tsakok T, Warren RB, Flohr C, Spuls P, Griffiths CEM, Barker J, Irvine AD, Smith CH; et al.

Abstract:

Link para artigo

[Rheumatology and COVID-19].

Dumusc A, Dan D.

Abstract:

Link para artigo

[Autoimmune diseases in the context of pandemic COVID-19].

Horisberger A, Moi L, Ribi C, Comte D.

Abstract:

Link para artigo

Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/Covid-19 pandemic.

Schulze-Koops H, Specker C, Iking-Konert C, Holle J, Moosig F, Krueger K.

Abstract:

Link para artigo

Response to 'Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?' by Moiseev et al.

Spinelli FR, Ceccarelli F, Di Franco M, Conti F.

Abstract:

Link para artigo

Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey.

Tomelleri A, Sartorelli S, Campochiaro C, Baldissera EM, Dagna L.

Abstract:

Link para artigo

Anti-inflammatory therapy may ameliorate the clinical picture of COVID-19.

Moutsopoulos HM.

Abstract:

Link para artigo

The impact of COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biologic therapy: the Northern Italy experience.

Gisondi P, Facheris P, Dapavo P, Piaserico S, Conti A, Naldi L, Cazzaniga S, Malagoli P, Costanzo A.

Abstract:

Link para artigo

[Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic].

Schulze-Koops H, Holle J, Moosig F, Specker C, Aries P, Burmester G, Fiehn C, Hoyer B, Krause A, Leipe J, Lorenz HM, Schneider M, Sewerin P, Voormann A, Wager U, Krüger K, Iking-Konert C; im Auftrag der Kommission Pharmakotherapie und des Vorstandes der Deutschen Gesellschaft für Rheumatologie..

Abstract:

Link para artigo

Case Report of a SARS-CoV-2 Infection in a Patient With Ulcerative Colitis on Tofacitinib.

Jacobs J, Clark-Snustad K, Lee S.

Abstract:

Link para artigo

Managing patients with rheumatic conditions during the covid-19 pandemic.

Caporali R, Favalli EG.

Abstract:

Link para artigo

Online management of rheumatoid arthritis during COVID-19 pandemic.

Zhang Y, Wang J, Zhao L, Xiao J, Shi Z.

Abstract:

Link para artigo

The conundrum of COVID-19 treatment targets: the close correlation with rheumatology. Response to: 'Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology pracitioners from India' by Gupta et al and 'Antirheumatic agents in covid-19: is IL-6 the right target?...

Monti S, Montecucco C.

Abstract:

Link para artigo

Biologics for psoriasis in COVID-19 era: what do we know?

Megna M, Napolitano M, Patruno C, Fabbrocini G.

Abstract:

Link para artigo

Rheumotologitsts' View on the Use of Hydroxychloroquine to Treat COVID-19.

Sun X, Ni Y, Zhang M.

Abstract:

Link para artigo

The Question of Whether to Remain on Therapy for Chronic Rheumatic Diseases in the Setting of the Covid-19 Pandemic.

Cron RQ, Chatham WW.

Abstract:

Link para artigo

Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis.

Favalli EG, Agape E, Caporali R.

Abstract:

Link para artigo

Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs.

Filocamo G, Minoia F, Carbogno S, Costi S, Romano M, Cimaz R; Pediatric Rheumatology Group of the Milan Area..

Abstract:

Link para artigo

Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic.

Kasperkiewicz M, Schmidt E, Fairley JA, Joly P, Payne AS, Yale ML, Zillikens D, Woodley DT.

Abstract:

Link para artigo

Patients with lupus are not protected from COVID-19.

Sawalha AH.

Abstract:

Link para artigo

Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.

Mathian A, Mahevas M, Rohmer J, Roumier M, Cohen-Aubart F, Amador-Borrero B, Barrelet A, Chauvet C, Chazal T, Delahousse M, Devaux M, Euvrard R, Fadlallah J, Florens N, Haroche J, Hié M, Juillard L, Lhote R, Maillet T, Richard-Colmant G, Palluy JB, Pha M, et al.

Abstract:

Link para artigo

Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biological treatment and renal transplanted recipients in maintenance immunosuppressive treatment.

Gisondi P, Zaza G, Del Giglio M, Rossi M, Iacono V, Girolomoni G.

Abstract:

Link para artigo

Characteristics and prognosis of patients with inflammatory bowel disease during the SARS-CoV-2 pandemic in the Basque Country (Spain).

Rodríguez-Lago I, Ramírez de la Piscina P, Elorza A, Merino O, Ortiz de Zárate J, Cabriada JL.

Abstract:

Link para artigo

COVID-19, osteoarthritis and women's health.

Mobasheri A.

Abstract:

Link para artigo

Translating IL-6 biology into effective treatments.

Choy EH, De Benedetti F, Takeuchi T, Hashizume M, John MR, Kishimoto T.

Abstract:

Link para artigo

Management of inflammatory bowel disease during COVID-19 pandemic.

Ribaldone DG, Astegiano M, Actis GC, Pellicano R.

Abstract:

Link para artigo

Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit.

Monti S, Montecucco C.

Abstract:

Link para artigo

Myositis as a manifestation of SARS-CoV-2.

Beydon M, Chevalier K, Al Tabaa O, Hamroun S, Delettre AS, Thomas M, Herrou J, Riviere E, Mariette X.

Abstract:

Link para artigo

SLE patients are not immune to covid-19: importance of sending the right message across.

Goyal M.

Abstract:

Link para artigo

Lupus anticoagulant is frequent in patients with Covid-19.

Harzallah I, Debliquis A, Drénou B.

Abstract:

Link para artigo

What is the true incidence of COVID-19 in patients with rheumatic diseases?

Favalli EG, Ingegnoli F, Cimaz R, Caporali R.

Abstract:

Link para artigo

To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic.

Parperis K.

Abstract:

Link para artigo

Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID).

Giollo A, Adami G, Gatti D, Idolazzi L, Rossini M.

Abstract:

Link para artigo

Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases.

Richez C, Lazaro E, Lemoine M, Truchetet ME, Schaeverbeke T.

Abstract:

Link para artigo

COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country.

Licciardi F, Giani T, Baldini L, Favalli EG, Caporali R, Cimaz R.

Abstract:

Link para artigo

Management of inflammatory bowel disease patients in the COVID-19 pandemic era: a Brazilian tertiary referral center guidance.

Queiroz NSF, Barros LL, Azevedo MFC, Oba J, Sobrado CW, Carlos AS, Milani LR, Sipahi AM, Dami√£o AOMC.

Abstract:

Link para artigo

Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?

Xie W, Wang Y, Zhang Z.

Abstract:

Link para artigo

Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?

Moiseev S, Avdeev S, Brovko M, Novikov P, Fomin V.

Abstract:

Link para artigo

The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19.

Perricone C, Triggianese P, Bartoloni E, Cafaro G, Bonifacio AF, Bursi R, Perricone R, Gerli R.

Abstract:

Link para artigo

Clinical and Autoimmune Characteristics of Severe and Critical Cases with COVID-19.

Zhou Y, Han T, Chen J, Hou C, Hua L, He S, Guo Y, Zhang S, Wang Y, Yuan J, Zhao C, Zhang J, Jia Q, Zuo X, Li J, Wang L, Cao Q, Jia E.

Abstract:

Link para artigo

Challenges in the Care of IBD Patients During the CoViD-19 Pandemic: Report From a "Red Zone" Area in Northern Italy.

Occhipinti V, Pastorelli L.

Abstract:

Link para artigo

COVID-19 and psoriasis : should we fear for patients treated with biologics?

Amerio P, Prignano F, Giuliani F, Gualdi G.

Abstract:

Link para artigo

Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs.

Song J, Kang S, Choi SW, Seo KW, Lee S, So MW, Lim DH.

Abstract:

Link para artigo

Faecal calprotectin indicates intestinal inflammation in COVID-19.

Effenberger M, Grabherr F, Mayr L, Schwaerzler J, Nairz M, Seifert M, Hilbe R, Seiwald S, Scholl-Buergi S, Fritsche G, Bellmann-Weiler R, Weiss G, Müller T, Adolph TE, Tilg H.

Abstract:

Link para artigo

Covid-19 infection in Crohn's disease under treatment with adalimumab.

Tursi A, Angarano G, Monno L, Saracino A, Signorile F, Ricciardi A, Papa A.

Abstract:

Link para artigo

Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia.

Guilpain P, Le Bihan C, Foulongne V, Taourel P, Pansu N, Maria ATJ, Jung B, Larcher R, Klouche K, Le Moing V.

Abstract:

Link para artigo

Experiences of Patients with Rheumatic Diseases in the US During Early Days of the COVID-19 Pandemic.

Michaud K, Wipfler K, Shaw Y, Simon TA, Cornish A, England BR, Ogdie A, Katz P.

Abstract:

Link para artigo

Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China.

An P, Ji M, Ren H, Su J, Ding NS, Kang J, Yin A, Zhou Q, Shen L, Zhao L, Jiang X, Xiao Y, Tan W, Lv X, Li J, Liu S, Zhou J, Chen H, Xu Y, Liu J, Chen M, Cao J, et al.

Abstract:

Link para artigo

Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries.

Gianfrancesco MA, Hyrich KL, Gossec L, Strangfeld A, Carmona L, Mateus EF, Sufka P, Grainger R, Wallace Z, Bhana S, Sirotich E, Liew J, Hausmann JS, Costello W, Robinson P, Machado PM, Yazdany J; COVID-19 Global Rheumatology Alliance Steering Committee..

Abstract:

Link para artigo

Successful Guselkumab treatment in a psoriatic patient affected with Cornelia de Lange Syndrome, and prosecution during the COVID-19 pandemic.

Mugheddu C, Dell'Antonia M, Sanna S, Agosta D, Atzori L, Rongioletti F.

Abstract:

Link para artigo

Inflammatory bowel diseases and COVID-19: the invisible enemy.

D'Amico F, Peyrin-Biroulet L, Danese S.

Abstract:

Link para artigo

Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period.

Iacucci M, Cannatelli R, Labarile N, Mao R, Panaccione R, Danese S, Kochhar GS, Ghosh S, Shen B.

Abstract:

Link para artigo

Maintaining the quality standards of care for inflammatory bowel disease patients during the COVID-19 pandemic.

Allocca M, Fiorino G, Furfaro F, Gilardi D, Radice S, D'Amico F, Zilli A, Danese S.

Abstract:

Link para artigo

[A cross sectional study on patients with inflammatory rheumatic diseases in terms of their compliance to their immunsuppressive medication during COVID-19 pandemic].

Schmeiser T, Broll M, Dormann A, Fräbel C, Hermann W, Hudowenz O, Keil F, Müller-Ladner U, Özden F, Pfeiffer U, Saech J, Schwarting A, Stapfer G, Steinchen N, Storck-Müller K, Strunk J, Thiele A, Triantafyllias K, Wassenberg S, Wilden E, Hasseli R.

Abstract:

Link para artigo

Impact of anti-tnfα antibodies on the risk of Covid-19 and its severity in patients with inflammatory Bowel Diseases.

Tursi A, Papa A.

Abstract:

Link para artigo

Will COVID-19 infection be less severe in ulcerative colitis than in Crohn's patients due to a lower rate of smokers?

Peyrin-Biroulet C, D'Amico F, Peyrin-Biroulet L.

Abstract:

Link para artigo

British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic.

Kennedy NA, Jones GR, Lamb CA, Appleby R, Arnott I, Beattie RM, Bloom S, Brooks AJ, Cooney R, Dart RJ, Edwards C, Fraser A, Gaya DR, Ghosh S, Greveson K, Hansen R, Hart A, Hawthorne AB, Hayee B, Limdi JK, Murray CD, Parkes GC, et al.

Abstract:

Link para artigo

Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19.

Li G, He X, Zhang L, Ran Q, Wang J, Xiong A, Wu D, Chen F, Sun J, Chang C.

Abstract:

Link para artigo

Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?

Di Altobrando A, Patrizi A, Bardazzi F.

Abstract:

Link para artigo

Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears.

Megna M, Ruggiero A, Marasca C, Fabbrocini G.

Abstract:

Link para artigo

Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times.

Brownstone ND, Thibodeaux QG, Reddy VD, Myers BA, Chan SY, Bhutani T, Liao W.

Abstract:

Link para artigo

COVID-19 and rheumatology: first steps towards a different future?

McInnes IB.

Abstract:

Link para artigo

Antirheumatic agents in covid-19: is IL-6 the right target?

Capecchi PL, Lazzerini PE, Volterrani L, Mazzei MA, Rossetti B, Zanelli G, Bennett D, Bargagli E, Franchi F, Cameli M, Valente S, Cantarini L, Frediani B.

Abstract:

Link para artigo

Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India.

Gupta L, Misra DP, Agarwal V, Balan S, Agarwal V.

Abstract:

Link para artigo

COVID-19, immune system response, hyperinflammation and repurposing anti-rheumatic drugs.

Tufan A, Avanoğlu Güler A, Matucci-Cerinic M.

Abstract:

Link para artigo

Dealing with COVID-19 in a Pediatric Rheumatology Unit in Italy.

Costi S, Caporali R, Cimaz R.

Abstract:

Link para artigo

Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times.

Brownstone ND, Thibodeaux QG, Reddy VD, Myers BA, Chan SY, Bhutani T, Liao W.

Abstract:

Link para artigo

Role of immunosuppressive therapy in rheumatic diseases concurrent with covid-19.

Lu C, Li S, Liu Y.

Abstract:

Link para artigo

Does hydroxychloroquine prevent the transmission of covid-19?

Heldwein FL, Calado A.

Abstract:

Link para artigo

SLE, hydroxychloroquine and no SLE patients with covid-19: a comment.

Joob B, Wiwanitkit V.

Abstract:

Link para artigo

Festina lente: hydroxychloroquine, covid-19 and the role of the rheumatologist.

Graef ER, Liew JW, Putman MS, Simard JF, Sirotich E, Berenbaum F, Duarte-García A, Grainger R, Harrison C, Konig MF, Korsten P, Proulx L, Richards DP, Robinson PC, Sattui SE, Ugarte-Gil MF, Young KJ, Kim AH, Sparks JA; COVID-19 Global Rheumatology Alliance..

Abstract:

Link para artigo

Immune Thrombocytopenic Purpura in a Patient with Covid-19.

Zulfiqar AA, Lorenzo-Villalba N, Hassler P, Andrès E.

Abstract:

Link para artigo

Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in sardinia (Italy).

Atzori L, Mugheddu C, Addis G, Sanna S, Satta R, Ferreli C, Atzori MG, Montesu MA, Rongioletti F.

Abstract:

Link para artigo

SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor.

Messina F, Piaserico S.

Abstract:

Link para artigo

Concerns related to COVID-19 pandemic among patients with Inflammatory Bowel Disease, and its influence on patients management.

Bodini G, Demarzo MG, Casagrande E, De Maria C, Kayali S, Ziola S, Giannini EG.

Abstract:

Link para artigo

Pathogenic Priming Likely Contributes to Serious and Critical Illness and Mortality in COVID-19 via Autoimmunity.

Lyons-Weiler J.

Abstract:

Link para artigo

Psoriasis and Psoriatic Arthritis: how to manage Immunosuppressants in COVID-19‚Äâdays.

Coletto LA, Favalli EG, Caporali R.

Abstract:

Link para artigo

Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?

Liu B, Li M, Zhou Z, Guan X, Xiang Y.

Abstract:

Link para artigo

COVID-19 - Considerations for the paediatric rheumatologist.

Hedrich CM.

Abstract:

Link para artigo

Biologics for psoriasis during COVID-19 outbreak.

Di Lernia V.

Abstract:

Link para artigo

COVID-19, syphilis and biologic therapies for psoriasis and psoriatic arthritis: A word of caution

.

Abstract:

Link para artigo

Adalimumab for Treatment of Hidradenitis Suppurativa During the COVID-19 Pandemic: Safety Considerations.

Blaszczak A, Trinidad JCL, Cartron AM.

Abstract:

Link para artigo

AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary.

Rubin DT, Feuerstein JD, Wang AY, Cohen RD.

Abstract:

Link para artigo

Rapid and Severe Covid-19 Pneumonia with Severe Acute Chest Syndrome in a Sickle Cell Patient Successfully Treated with Tocilizumab.

De Luna G, Habibi A, Deux JF, Colard M, d'Alexandry d'Orengiani ALPH, Schlemmer F, Joher N, Kassasseya C, Pawlotsky JM, Ourghanlian C, Michel M, Mekontso-Dessap A, Bartolucci P.

Abstract:

Link para artigo

Telemedicine for Pediatric Inflammatory bowel disease in the Era of COVID-19.

Verstraete SG, Sola AM, Ali SA.

Abstract:

Link para artigo

A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in Coronavirus Disease-19 (COVID-19).

Shah S, Das S, Jain A, Misra DP, Negi VS.

Abstract:

Link para artigo

Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets.

Misra DP, Agarwal V, Gasparyan AY, Zimba O.

Abstract:

Link para artigo

Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic.

Torres T, Puig L.

Abstract:

Link para artigo

Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients.

Sawalha AH, Zhao M, Coit P, Lu Q.

Abstract:

Link para artigo

Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.

Jakhar D, Kaur I.

Abstract:

Link para artigo

Possible Consequences of a Shortage of Hydroxychloroquine for Lupus Patients Amid the COVID-19 Pandemic.

Peschken CA.

Abstract:

Link para artigo

Learning from Adversity: Lessons from the COVID-19 Crisis.

Putman MS, Ruderman EM.

Abstract:

Link para artigo

Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning.

Shoenfeld Y.

Abstract:

Link para artigo

SECURE-Psoriasis: a de-identified registry of psoriasis patients diagnosed with COVID-19.

Balogh EA, Heron C, Feldman SR, Huang WW.

Abstract:

Link para artigo

Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon

Haşlak F, Yıldız M, Adrovic A, Barut K, Kasapçopur Ö.

Abstract:

Link para artigo

Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy.

Ceribelli A, Motta F, De Santis M, Ansari AA, Ridgway WM, Gershwin ME, Selmi C.

Abstract:

Link para artigo

ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia.

Rivellese F, Prediletto E.

Abstract:

Link para artigo

The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease.

McGonagle D, Sharif K, O'Regan A, Bridgewood C.

Abstract:

Link para artigo

What is the role of rheumatologists in the era of COVID-19?

Marotto D, Sarzi-Puttini P.

Abstract:

Link para artigo

Biologic therapy for psoriasis during the covid-19 outbreak is not a choice.

Bardazzi F, Loi C, Sacchelli L, Di Altobrando A.

Abstract:

Link para artigo

COVID-19, syphilis and biologic therapies for psoriasis and psoriatic arthritis: A word of caution.

Kansal NK.

Abstract:

Link para artigo

Management of Inflammatory Bowel Diseases in the Wake of COVID-19 Pandemic.

Pasha SB, Fatima H, Ghouri YA.

Abstract:

Link para artigo

COVID-19 in children and altered inflammatory responses.

Molloy EJ, Bearer CF.

Abstract:

Link para artigo

Immunosuppression drug-related and clinical manifestation of Coronavirus disease 2019: A therapeutical hypothesis.

Romanelli A, Mascolo S.

Abstract:

Link para artigo

COVID-19 in post-transplantation patients- report of two cases.

Huang J, Lin H, Wu Y, Fang Y, Kumar R, Chen G, Lin S.

Abstract:

Link para artigo

A familial cluster, including a kidney transplant recipient, of Coronavirus Disease 2019 (COVID-19) in Wuhan, China.

Chen S, Yin Q, Shi H, Du D, Chang S, Ni L, Qiu H, Chen Z, Zhang J, Zhang W.

Abstract:

Link para artigo

The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic.

Robinson PC, Yazdany J.

Abstract:

Link para artigo

Hydroxychloroquine: a potential ethical dilemma for rheumatologists during the COVID-19 pandemic.

Scuccimarri R, Sutton E, Fitzcharles MA.

Abstract:

Link para artigo

Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.

Monti S, Balduzzi S, Delvino P, Bellis E, Quadrelli VS, Montecucco C.

Abstract:

Link para artigo

COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD.

Mihai C, Dobrota R, Schröder M, Garaiman A, Jordan S, Becker MO, Maurer B, Distler O.

Abstract:

Link para artigo

To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic.

Spinelli FR, Ceccarelli F, Di Franco M, Conti F.

Abstract:

Link para artigo

The COVID-19 outbreak and rheumatologic skin diseases.

Arora G, Kassir M, Jafferany M, Galadari H, Lotti T, Satolli F, Sadoughifar R, Sitkowska Z, Goldust M.

Abstract:

Link para artigo

COVID-19 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto group of ESPGHAN.

Turner D, Huang Y, Martín-de-Carpi J, Aloi M, Focht G, Kang B, Zhou Y, Sanchez C, Kappelman MD, Uhlig HH, Pujol-Muncunill G, Ledder O, Lionetti P, Dias JA, Ruemmele FM, Russell RK; Paediatric IBD Porto group of ESPGHAN..

Abstract:

Link para artigo

The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality.

Zhang C, Wu Z, Li JW, Zhao H, Wang GQ.

Abstract:

Link para artigo

Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs.

Georgiev T.

Abstract:

Link para artigo

COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medication adherence.

Venerito V, Lopalco G, Iannone F.

Abstract:

Link para artigo

How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1.

Conti P, Gallenga CE, Tetè G, Caraffa A, Ronconi G, Younes A, Toniato E, Ross R, Kritas SK.

Abstract:

Link para artigo

Arthralgia as an initial presentation of COVID-19: observation.

Joob B, Wiwanitkit V.

Abstract:

Link para artigo

COVID-19 outbreak and inflammatory bowel disease management: a questionnaire survey from realistic practice.

Bai X, Yang H, Qian J.

Abstract:

Link para artigo

Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?

Ritchie AI, Singanayagam A.

Abstract:

Link para artigo

Are patients with inflammatory bowel disease at increased risk for Covid-19 infection?

Monteleone G, Ardizzone S.

Abstract:

Link para artigo

Management of IBD during the COVID-19 outbreak: resetting clinical priorities.

Danese S, Cecconi M, Spinelli A.

Abstract:

Link para artigo

Inflammatory bowel disease care in the COVID-19 pandemic era: the Humanitas, Milan experience.

Fiorino G, Allocca M, Furfaro F, Gilardi D, Zilli A, Radice S, Spinelli A, Danese S.

Abstract:

Link para artigo

The Rheumatologist's Role in COVID-19.

Cron RQ, Chatham WW.

Abstract:

Link para artigo

Don't forget chronic lung and immune conditions during covid-19, says WHO.

Thornton J.

Abstract:

Link para artigo

Are my patients with rheumatic diseases at higher risk of COVID-19?

Figueroa-Parra G, Aguirre-Garcia GM, Gamboa-Alonso CM, Camacho-Ortiz A, Galarza-Delgado DA.

Abstract:

Link para artigo

COVID-19 infection and rheumatoid arthritis: Faraway, so close!

Favalli EG, Ingegnoli F, De Lucia O, Cincinelli G, Cimaz R, Caporali R.

Abstract:

Link para artigo

Should biologics for psoriasis be interrupted in the era of COVID-19?

Lebwohl M, Rivera-Oyola R, Murrell DF.

Abstract:

Link para artigo

The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China.

Yang Y, Peng F, Wang R, Guan K, Jiang T, Xu G, Sun J, Chang C.

Abstract:

Link para artigo

The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak.

Rothan HA, Byrareddy SN.

Abstract:

Link para artigo

The association between severe or death COVID-19 and autoimmune disease: a systematic review and meta-analysis

Liu M, Gao Y, Zhang Y, Shi S, Chen Y, Tian J.

Abstract:

Link para artigo

American College of Rheumatology Guidance for the Management of Adult Patients with Rheumatic Disease During the COVID-19 Pandemic.

Mikuls TR, Johnson SR, Fraenkel L, Arasaratnam RJ, Baden LR, Bermas BL, Chatham W, Cohen S, Costenbader K, Gravallese EM, Kalil AC, Weinblatt ME, Winthrop K, Mudano AS, Turner A, Saag KG.

Abstract:

Link para artigo

Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/Covid-19 pandemic.

Schulze-Koops H, Specker C, Iking-Konert C, Holle J, Moosig F, Krueger K.

Abstract:

Link para artigo

Immune Thrombocytopenic Purpura in a Patient with Covid-19.

Zulfiqar AA, Lorenzo-Villalba N, Hassler P, Andrès E.

Abstract:

Link para artigo

Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in sardinia (Italy).

Atzori L, Mugheddu C, Addis G, Sanna S, Satta R, Ferreli C, Atzori MG, Montesu MA, Rongioletti F.

Abstract:

Link para artigo

Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic.

Torres T, Puig L.

Abstract:

Link para artigo

Management of Inflammatory Bowel Diseases in the Wake of COVID-19 Pandemic.

Pasha SB, Fatima H, Ghouri YA.

Abstract:

Link para artigo

Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs.

Georgiev T.

Abstract:

Link para artigo